Bayer’s Trasylol Raises Kidney Risk, FDA Regulators

FDA regulators said that Bayer’s injectable Trasylol, used to control bleeding in bypass surgery, raised the risk of kidney damage in clinical studies and may also increase the chance of death in patients.
Medical Marketing & Media